CG Oncology CGON
NASDAQ CGON
$72.64 -2.10 (-2.81%)
At close: Nov 10, 2026 · 4:00 PM EST

CG Oncology (CGON) Invested Capital (2022 - 2026)

Updated

CG Oncology (CGON) posted Invested Capital of $1.03 billion for Q2 2026, down 5.7% from the prior quarter.

Analysis

CG Oncology (CGON) Invested Capital (2022 - 2026) Analysis & Trends

For FY2025, CG Oncology's Invested Capital came in at $755.6 million, up 3.0% from FY2024.

  • In prior years, CG Oncology's Invested Capital was $733.38 million in FY2024.
  • Quarterly Invested Capital has run from a low of $690.64 million in Q3 2025 to a high of $1.09 billion in Q1 2026 over five years.
  • According to Business Quant data, Invested Capital for the three prior quarters was $1.09 billion (Q1 2026), $755.6 million (Q4 2025) and $690.64 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 89.77 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 126.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 76.32 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 98.72 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 45.14 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 68.36 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 39.27 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 151.97 Bn
10 CG Oncology 6.49 Bn 2.66 Bn -1.07 Mn 993.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 993.97 Mn
Jun 30, 2026 1.03 Bn
Mar 31, 2026 1.09 Bn
Dec 31, 2025 755.60 Mn
Sep 30, 2025 690.64 Mn
Dec 31, 2024 733.38 Mn
Dec 31, 2023 -118.34 Mn
Dec 31, 2022 -62.20 Mn
API Access

CG Oncology Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=CGON&period=max&api_key=YOUR_API_KEY